Report Overview

Increased demand for minimally invasive surgeries over open surgeries and growing concern about sedentary lifestyles, and an increase in the senior population are expected to drive United States Gynecology Robotic Surgery Market at a robust growth rate during the forecast period 2022 and 2028

United States Gynecology Robotic Surgery Market - Industry Trends & Forecast Report, 2028

United States Gynecology Robotic Surgery Market size is projected to grow at a CAGR of 15.8% during the forecast period between 2022 and 2028, to reach a value of USD 3.21 billion by 2028. Robotic Surgery systems include different components like instrumentality, software, and services to perform surgeries including cardiac and gynecological. Furthermore, they are minimally invasive with minimal to no post-surgical complications. In the last three decades, minimally invasive surgery (MIS) has become a notable medical advancement. It revolutionized surgery by offering well-proven advantages over traditional open surgery, including reduced surgical trauma and incision-related complications such as surgical-site infections, postoperative discomfort, and hernia, as well as shorter hospital stays and improved cosmetic outcomes. Traditional laparoscopy, on the other hand, has limitations, including a two-dimensional (2D) monitor that limits in-depth perception, camera instability, limited range of motion, and steep learning curves.

United States Gynecology Robotic Surgery Market

Growth Drivers

Growing demand for less invasive gynecology surgery

Less invasive techniques have several advantages over open surgeries, including quicker recovery, shorter procedures, less problems, and reduced readmission rates. As a result, the benefits of minimally invasive operations are driving up demand not only in North America, but also in Europe and Asia Pacific. Due to technological breakthroughs in surgical robotic systems, as well as technologies that are used to execute minimally invasive treatments, such as the introduction and improvements in robotic surgical systems, the number of open surgeries has decreased significantly over the last two decades.

Gradual shift toward Hysterectomies

Hysterectomies are increasingly being performed as minimally invasive outpatient operations in the United States. In 2019, outpatient settings account for 70-80% of total benign hysterectomies in the United States, up from 10-15% in 2008. During the forecast period, this is expected to boost market growth.

Effect from Endometriosis

Endometriosis is estimated to affect 11% of women of reproductive age. The American Cancer Society estimates that 13,800 new cases of cervical cancer will be detected in the United States in 2020. Furthermore, with the approval of the da Vinci robotic surgical system for gynecological surgery, the usage of robotic surgery for the treatment of gynecological problems has increased dramatically. The market for gynecological robotic surgery in the United States is predicted to develop because of this.

Opportunities

Gynecological diseases are becoming more common as sedentary lifestyle and the growing elderly population in the United States. This is expected to drive the expansion of the gynecologic robotic surgery market in the United States in coming years.

Restraining Factors

Low reimbursement rate

The Centers for Medicare and Medicaid Services boosted payment rates for most minimally invasive gynecological outpatient procedures to 82% in 2016. The CMS, on the other hand, includes robotic surgery in MIS treatments, resulting in a lower reimbursement rate. As a result, surgeons are preferring laparoscopic or other MIS methods to robotic surgery. This, combined with the high expense, is a major factor for the decreased acceptance of robotic surgery, particularly among those in private practice.

Impact of COVID-19 on United States Gynecology Robotic Surgery Market

COVID-19 pandemic has disrupted the demand and supply chain, which has had a significant impact on the medical device industry. The Centers for Medicare & Medicaid Services (CMS) declared in March 2020 that all elective and non-essential medical, surgical, and dental procedures would be postponed or cancelled. The decision was made to set aside and reallocate healthcare resources for COVID-19 patients. However, sales of medical devices, especially robotic systems, came to a halt. It has a detrimental influence on the number of robotic gynecological procedures performed and income generated by the market's key players.

Intuitive Surgical Inc., for example, had a 6.2% drop in revenue in the first half of 2020 compared to the same period in 2019. In comparison to the previous year, the company saw a considerable drop in the number of da Vinci surgeries. According to a research study conducted by the American Hospital Association, during the pandemic, hospitals and health systems in the United States saw a 20% drop in inpatient volume and a 35% drop in outpatient volume. This, combined with the closure of production plants and restrictions on people's movement, is predicted to severely impede the market.

United States Gynecology Robotic Surgery Market

Segmental Coverage

United States Gynecology Robotic Surgery Market – By Type

On basis of product type, the United States gynecology robotic surgery market is segmented into instrument and accessories and robotic platform & services.

United States Gynecology Robotic Surgery Market – By Application

Depending on the application, the United States gynecology robotic surgery market is segmented into Hysterectomy, Sacrocolpopexy & Myomectomy, and Gynecologic Malignancy.

United States Gynecology Robotic Surgery Market – By End User

Depending on the end user, the United States gynecology robotic surgery market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Physicians’ Offices & Others. Ambulatory surgery centers are predicted to grow at the fastest rate between 2022 and 2028. The transition from inpatient to outpatient gynecological procedures has been made possible by technical advancements and a rising emphasis on robotic surgery. This, together with the increasing number of ASCs, is expected to move the business forward. In addition, the growing use of surgical robots in hospitals and measures to minimize the burden of surgeons and other medical staff are driving the expansion of the hospitals and clinics segment.

Competitive Analysis

Manufacturers are concentrating their efforts on entering the US market to encourage the adoption of robotic systems. Many manufacturers, such as Titan Medical Inc. and CMR Surgical, are increasing their R&D activities to enter the United States market as demand for minimally invasive hysterectomies grows. Regulatory approvals and increased efforts by robotic systems manufacturers to introduce products in the United States are expected to boost demand for gynecological robotic surgery. CMR Surgical Ltd., Medtronic, Intuitive Surgical Inc., are leading companies in US gynecology robotic surgery market.

Recent Developments

Major companies in United States gynecology robotic surgery market include Intuitive Surgical, Inc., Olympus Corporation, Medtronic Plc, Stryker Corporation, Asensus Surgical US, Inc., Titan Medical Inc., Verb Surgical Inc., and Medrobotics Corporation. Titan Medical Inc. is currently developing the SPORT robotic surgical system for a variety of applications, including gynecology, and plans to enter the US market once regulatory permissions are received. Olympus, a global leader in developing and delivering revolutionary medical and surgical solutions, launched the ENDOEYE FLEX 3D and the FlexDex Needle Driver (3D/FlexDex) laparoscopic surgical solution in 2018. The business wanted to combine its breakthrough ENDOEYE FLEX 3D laparoscopic imaging technology with FlexDex's wristed needle-driver to increase limited access surgery capabilities while providing a cost-effective robotic solution through an exclusive US distribution arrangement. Many treatments, including general surgery and gynecological specialty, can benefit from 3D/FlexDex.

Scope of the Report

By Type

• Instruments & Accessories

• Robotic Platform

• Services

By Application

• Hysterectomy

• Sacrocolpopexy & Myomectomy

• Gynecologic Malignancy

 By End User

• Hospitals & Clinics

• Ambulatory Surgical Centres

• Physicians’ Offices

• Others